|
| 近岸蛋白(688137)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-09-29 | 714.50 | 10.18% | 3982.04 | 3035.50 | 3211.04 | 45.76% | 首发原股东限售股份 | | 2024-09-30 | 56.50 | 0.81% | 3267.54 | 3750.00 | 3232.71 | 46.07% | 首发战略配售股份 | | 2024-06-26 | 263.16 | 3.75% | 3232.71 | 3784.83 | 2969.55 | 42.32% | 首发原股东限售股份 | | 2023-12-25 | 238.00 | 3.39% | 2954.40 | 4063.14 | 1704.40 | 24.29% | 首发原股东限售股份 | | 2023-10-09 | 1012.00 | 14.42% | 2716.40 | 4301.14 | 1704.40 | 24.29% | 首发原股东限售股份 | | 2023-03-29 | 71.48 | 1.02% | 1697.88 | 5319.66 | 1626.41 | 23.18% | 首发机构配售股份 | | 2022-09-29 | 1626.41 | 23.18% | 1626.41 | 5391.14 | 1626.41 | 23.18% | 首发一般股份 |
|